Open access publisher BioMed Central has announced that a total of 71 journals in its publishing portfolio have seen their Impact Factors increase in the recently published Journal Citation Report 2013. This year 12 journals received their first Impact Factor, so 162 journals out of 265 BioMed Central journals now have an Impact Factor, with a further seven being tracked by Thomson Reuters.
Standing out among the success stories are several society journals published in partnership with BioMed Central that have leapt forward in their rankings since making the transition to open access.
The Journal of Cardiovascular Magnetic Resonance receives a new Impact Factor of 5.11, up from 2.15 when it moved to BioMed Central and converted from the subscription model in 2008. The journal, the official publication of the Society of Cardiovascular Magnetic Resonance, saw a first significant increase to 4.33 when the calculation for the first time became solely based on open access content in 2011.
The Irish Veterinary Journal finds itself on the same upward trajectory, following its move to BioMed Central in 2011. The new Impact Factor for the journal, calculated based on open access content alone, is 1.71, up from last year's 0.43. This new Impact Factor sees the Irish Veterinary Journal, founded in 1946 and published in partnership with Veterinary Ireland, move up from the third quartile to the first quartile in the Veterinary Sciences category.
BioMed Central's flagship journals have also seen increases in their Impact Factors over last year. Genome Biology now has an Impact Factor of 10.5, which makes the journal fourth out of 165 in the Biotechnology and Applied Microbiology category. Genome Medicine has grown to 4.94 after receiving its first Impact Factor of 3.91 last year. BMC Medicine has seen a 9% increase with the Impact Factor rising to 7.28 and BMC Biology's has risen by 14% to 7.43.
